Insider · CIK 0001789815
Ourania Tatsis
Files at VRTX (VERTEX PHARMACEUTICALS INC / MA), VERV (Verve Therapeutics, Inc.). First filing Dec 5, 2025, latest Dec 5, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VRTX: VERTEX PHARMACEUTICALS INC / MA
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | VERTEX PHARMACEUTICALS INC / MA | $2.0M 4,500 shares | -9% | +26% from low-10% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | VRTX VERTEX PHARMACEUTICALS INC / MA | SOpen-market sale Common Stock10b5-1 | -4,500 | $449.99 | $2.0M | 46,793 | Dec 5, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -267,541 | - | - | 0 | Jul 28, 2025 |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -42,200 | - | - | 0 | Jul 28, 2025 |
| Jun 5, 2025 | VERV Verve Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +42,200 | $0.00 | $0 | 42,200 | Jun 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.